Business
Perimeter Medical Imaging Announces Expansion of ATLAS AI Project with Installation of OTISTM for AI development at Leading Cancer Care Center, MD Anderson
400 Patients Expected to be Enrolled in CPRIT-Backed Artificial Intelligence Development Stu...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"Perimeter Medical Imaging Announces Expansion of ATLAS AI Project with Installation of OTISTM for AI development at Leading Cancer Care Center, MD Anderson400 Patients Expected to be Enrolled in CPRIT-Backed Artificial Intelligence Development Study in Breast CancerDALLAS, TX / ACCESSWIRE / July 27, 2020 / Perimeter Medical Imaging, AI Inc. (TSXV:PINK) today announced the installation of their OTISTM device at the University of Texas MD Anderson Cancer Center (MD Anderson), to further develop ImgAssist AI technology marking an important milestone in this collaboration and Perimeter's ATLAS AI Project.Initiated in mid-July, the ATLAS AI Project allows Perimeter to collaborate with industry-leading cancer care centers that will use OTIS™ - its proprietary ultra-high resolution imaging platform - to collect images of breast tumors from approximately 400 patients for the purpose of training and testing Perimeter's ImgAssist AI technology. This technology, which is currently under development, is designed to utilize a machine learning model to help surgeons identify, in real-time, if cancer is still present when performing breast-conserving surgery (lumpectomy). This study was made possible, in part, by a $7.4 million grant awarded by the Cancer Prevention and Research Institute of Texas (CPRIT), a leading state body funding cancer research.Jeremy Sobotta, President and CFO stated, \"Initiation at MD Anderson is an important milestone in part one of our ATLAS AI Project and marks the next step in our development and clinical validation efforts for our ImgAssist AI software. MD Anderson is one of the largest breast cancer centers in the United States, treating approximately 40,000 patients a year, and is a valued collaborator as we strive to help physicians improve surgical outcomes for breast cancer patients by providing an additional tool for real-time margin visualization and assessment.\"A randomized, multi-site pivotal study will be conducted during the second part of the ATLAS AI Project to test Perimeter's OTIS™ platform with ImgAssist AI against the current standard of care and assess the impact on the re-operation rate for patients undergoing breast conservation surgery.Perimeter's OTIS™ technology delivers real-time, ultra-high resolution, sub-surface images of an excised tissue specimen. ImgAssist is be...